Activity of quinolones against Chlamydia pneumoniae

Related Experiment Video

Updated: Aug 8, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

M R Hammerschlag1

  • 1Department of Pediatrics, SUNY Health Science Center at Brooklyn, USA. mhammerschlag@pol.net

Drugs
|December 20, 1999
PubMed

Insights

Quinolone antibiotics are used for respiratory infections like pneumonia, but their effectiveness against Chlamydia pneumoniae is not well-established. More research is needed to confirm clinical efficacy beyond lab results.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Quinolones are widely used for community-acquired pneumonia, targeting common bacteria and atypical pathogens like Chlamydia pneumoniae.
  • Chlamydia pneumoniae is linked to a significant portion of adult community-acquired pneumonia and emerging non-respiratory conditions such as atherosclerosis.
  • Current treatment data for Chlamydia pneumoniae respiratory infections are limited, with existing studies relying on serological diagnosis rather than microbiological assessment.

Purpose of the Study:

  • To evaluate the clinical efficacy of quinolone antibiotics in treating respiratory infections caused by Chlamydia pneumoniae.
  • To address the gap in microbiological efficacy data for quinolone treatment of Chlamydia pneumoniae infections.
  • To investigate the correlation between in vitro activity and in vivo efficacy of quinolones against Chlamydia pneumoniae.

Main Methods:

  • Review of existing literature on quinolone treatment for respiratory infections.
  • Analysis of studies utilizing serological diagnosis for Chlamydia pneumoniae infections.
  • Comparison of in vitro antimicrobial activity data with available clinical outcomes.

Main Results:

  • Published quinolone treatment studies for Chlamydia pneumoniae have primarily used serological diagnosis, limiting assessment of microbiological cure.
  • While quinolones demonstrate in vitro activity against Chlamydia pneumoniae, anecdotal evidence suggests this may not consistently translate to clinical efficacy.
  • There is a lack of robust clinical trials assessing the direct microbiological impact of quinolones on Chlamydia pneumoniae infections.

Conclusions:

  • The microbiological efficacy of quinolones for treating Chlamydia pneumoniae respiratory infections remains unconfirmed due to reliance on indirect diagnostic methods.
  • Further clinical studies are essential to validate the effectiveness of quinolones against Chlamydia pneumoniae and to understand the in vitro-in vivo correlation.
  • Improved diagnostic approaches and well-designed trials are needed to guide optimal therapeutic strategies for Chlamydia pneumoniae infections.

More Related Videos

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds07:13

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...